Hospital
Five Rivers Medical Center INC.
Five Rivers Medical Center INC. was paid $2.00M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 23% of everything it billed.
33Billing provider infoFIVE RIVERS MEDICAL CENTER INC.
POCAHONTAS, AR 72455
POCAHONTAS, AR 72455
33aNPI1528360989assigned 11/17/2010
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.00M
24GClaims100,076
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arkansas
Rank by total paid#26 of 49
Median peer was paid$2.62M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,481 | $169K | |
| 2019 | 13,466 | $252K | |
| 2020 | 11,575 | $223K | |
| 2021 | 15,976 | $379K | |
| 2022 | 15,586 | $349K | |
| 2023 | 16,718 | $360K | |
| 2024incomplete | 12,274 | $262K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23% | 12,105 | 2,026 | $461K |
| 70450 | Computed tomography, head or brain; without contrast material | 7.5% | 1,370 | 1,217 | $150K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.4% | 797 | 694 | $127K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.5% | 1,446 | 1,220 | $90K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.5% | 1,716 | 1,427 | $90K |
| 80053 | Comprehensive metabolic panel | 4.5% | 6,587 | 5,642 | $89K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.0% | 5,598 | 4,610 | $81K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.4% | 864 | 713 | $69K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 9,130 | 7,141 | $61K |
| 83880 | 3.0% | 3,579 | 2,853 | $59K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.7% | 1,286 | 1,060 | $54K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 6,604 | 5,005 | $50K |
73 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 1,459 | $49K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 644 | $42K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 748 | $35K |
| 84145 | 1.7% | 1,864 | $35K | |
| 71045 | Radiologic examination, chest; single view | 1.7% | 3,015 | $34K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,760 | $29K |
| 84484 | 1.4% | 2,640 | $28K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 167 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,758 | $23K |
| 97161 | 1.1% | 313 | $21K | |
| 87400 | <1% | 3,043 | $20K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 490 | $17K |
| 85027 | <1% | 2,134 | $17K | |
| 84703 | <1% | 1,435 | $17K | |
| 80061 | Lipid panel | <1% | 1,473 | $16K |
| 81001 | <1% | 4,949 | $15K | |
| 83605 | <1% | 1,008 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,192 | $14K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 490 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 160 | $12K |
| 86403 | <1% | 837 | $11K | |
| 83690 | <1% | 1,041 | $10K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 136 | $10K |
| 87070 | <1% | 1,059 | $10K | |
| 87040 | <1% | 653 | $8K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 47 | $7K |
| 87430 | <1% | 521 | $7K | |
| 80305 | <1% | 642 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 243 | $7K |
| 83735 | <1% | 1,133 | $6K | |
| 87420 | <1% | 542 | $6K | |
| 86756 | <1% | 327 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 735 | $5K |
| 87076 | <1% | 892 | $5K | |
| 87186 | <1% | 1,030 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,233 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 58 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 161 | $3K |
| 94760 | <1% | 306 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 541 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 59 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $2K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 18 | $2K |
| 85610 | <1% | 648 | $2K | |
| 82607 | <1% | 94 | $2K | |
| 85730 | <1% | 331 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 49 | $1K |
| 83615 | <1% | 233 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 53 | $674.14 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 57 | $615.68 |
| 71010 | <1% | 94 | $594.00 | |
| 97001 | <1% | 16 | $543.84 | |
| 93226 | <1% | 17 | $415.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 151 | $402.44 |
| 73610 | <1% | 13 | $387.39 | |
| 85378 | <1% | 57 | $293.82 | |
| 80076 | <1% | 41 | $269.09 | |
| 93225 | <1% | 17 | $257.82 | |
| 84702 | <1% | 16 | $174.85 | |
| 82565 | <1% | 26 | $151.10 | |
| 93041 | <1% | 62 | $133.74 | |
| 73030 | <1% | 15 | $113.57 | |
| 83520 | <1% | 22 | $73.96 | |
| 82150 | <1% | 12 | $64.82 | |
| 82040 | <1% | 30 | $56.64 | |
| 81003 | <1% | 14 | $22.40 | |
| A9270 | Non-covered item or service | <1% | 665 | $10.63 |
| 81015 | <1% | 15 | $4.34 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 44 | $0.18 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 94 | $0.00 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 0% | 26 | $0.00 |
| 93000 | 0% | 81 | $0.00 | |
| 86769 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARYMON, RANDALL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Five Rivers Medical Center INC. | Pocahontas, AR | $315K |
| Five Rivers Medical Center INC | Pocahontas, AR | $55K |
| Five Rivers Medical Center INC | Pocahontas, AR | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.